Stock Price Quote

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE558.7049.25 (+9.67 %)
PREV CLOSE ( ) 509.45
OPEN PRICE ( ) 521.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 48646
TODAY'S LOW / HIGH ( )521.00 600.00
52 WK LOW / HIGH ( )365 621.4
NSE560.3551.15 (+10.05 %)
PREV CLOSE( ) 509.20
OPEN PRICE ( ) 529.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 560.35 (4129)
VOLUME 693920
TODAY'S LOW / HIGH( ) 520.20 609.00
52 WK LOW / HIGH ( )365.8 623.15
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-11 1990
Management Info
Sivalinga Prasad Vasireddi - Chairman Harita Vasireddi - Managing Director
Registered Office

Address Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R District,
Hyderabad,
Telangana-500051

Phone 040- 27264141

Email shares@vimta.com

Website www.vimta.com

Registrars Details
Cil Securities Ltd
214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,,Hyderabad
Listing : BSE, NSE, MCX

NEWS

01Apr Amalgamation
Inter alia, approved the Scheme of Amalgamation of Emtac Laboratories Pr..
02Mar Vimta Labs gets grants-in-aid from Min
Vimta Labs has received Grants-in-aid (GIA) of Rs 4.09 crore from Minist..
02Mar Vimta Labs informs about updates
Vimta Labs has informed regarding Grant in aid (GIA) of Rs 409.49 lakhs..
28Feb Announcement under Regulation 30 (LOD
Allotment of 5218 Equity shares under Vimta Labs Employee Stock Option P..
24Feb Vimta Labs informs about press release
With reference to letter no. VLL/Sh/089/2023-24 dated 23rd February 2024..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit94.55472.990000000001
Gross Profit 125.98 638.310000000001
Operating Profit 217.74970.150000000001
Net Sales 800.973151.16

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  6217.15 (4.47%)
M.Cap ( in Cr)103713.42
Abbott India (BSE)
peergroup  25725.00 (1.03%)
M.Cap ( in Cr)54663.83
Bharat Parenterals (BSE)
peergroup  1701.80 (10.00%)
M.Cap ( in Cr)990.39
Alkem Laboratories (BSE)
peergroup  4857.90 (3.10%)
M.Cap ( in Cr)58083.48
NGL Fine-Chem (BSE)
peergroup  2711.85 (3.47%)
M.Cap ( in Cr)1675.39

Shareholding Pattern

NON-INSTITUTION 56.45%
PROMOTERS 36.92%
MUTUAL FUNDS/UTI 1.49%
FI/BANKS/INSURANCE 0.01%
GOVERNMENT 0%
FII 0%

About Vimta Labs Ltd.

Vimta Labs Ltd. was incorporated in the year 1990. Its today's share price is 558.7. Its current market capitalisation stands at Rs 1238.67 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3151.16 Cr and Total Income of Rs.3185.84 Cr. The company's management includes G Purnachandra Rao, Yalamanchili Prameela Rani, Sujani Vasireddi, Yadagiri R Pendri, Sanjay Dave, Satya Sreenivas Neerukonda, Harriman Vungal, Harita Vasireddi, Sivalinga Prasad Vasireddi.

It is listed on the BSE with a BSE Code of 524394 , NSE with an NSE Symbol of VIMTALABS and ISIN of INE579C01029. It's Registered office is at Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R DistrictHyderabad-500051, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Gattamaneni & Co, JVSL & Associates, Sarathy & Balu

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.